Takeda Pharmaceutical annual return on equity
2018
2019
2020
2021
2022
2023
2024
2025
2026
Takeda Pharmaceutical Return on Equity (ROE) Growth & History (TAK)
Takeda Pharmaceutical's return on equity was −2.12% for fiscal 2026.
View full Takeda Pharmaceutical company overviewTakeda Pharmaceutical annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-03-31 | −2.12% | −3.64 pp |
| 2025 | 2025-03-31 | 1.52% | −0.59 pp |
| 2024 | 2024-03-31 | 2.12% | −3.15 pp |
| 2023 | 2023-03-31 | 5.27% | +1.03 pp |
| 2022 | 2022-03-31 | 4.24% | −3.36 pp |
| 2021 | 2021-03-31 | 7.60% | +6.71 pp |
| 2020 | 2020-03-31 | 0.89% | −2.87 pp |
| 2019 | 2019-03-31 | 3.76% | −5.70 pp |
| 2018 | 2018-03-31 | 9.46% | — |
Takeda Pharmaceutical quarterly return on equity
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2027 | 2026-06-30 | 1.51% | −0.29 pp |
| Q4 2026 | 2026-03-31 | −4.89% | — |
| Q3 2026 | 2025-12-31 | 1.40% | — |
| Q2 2026 | 2025-09-30 | −0.17% | — |
| Q1 2026 | 2025-06-30 | 1.80% | — |
Takeda Pharmaceutical return on equity trends
Over the last five fiscal years, Takeda Pharmaceutical's return on equity decreased from 7.60% to −2.12%, a change of −9.72 percentage points. The latest reported quarter, Q1 2027, shows 1.51%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Takeda Pharmaceutical source filings ↗